优先考虑十一-十九-白血病抑制剂作为口服可用的候选药物,用于急性髓性白血病
Xuejiao Shirley Guo1, Sandeep Atla1, Satyanarayana Nyalata1
1Texas A&M Drug Discovery Center and Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
Journal of medicinal chemistry
|November 12, 2024
概括
研究人员开发了针对ENL的强效抑制剂SR-C-107 (R),用于治疗急性髓性白血病 (AML). 这种新的候选药物在临床前研究中显示出显著的希望,以改善AML患者的存活率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 急性髓性白血病 (AML) 是一种致命的血液性恶性瘤.
- 瘤性MLL重组驱动AML的生长,依赖于ENL蛋白质.
- 用小分子准ENL是AML的治疗策略.
研究的目的:
- 开发和评估用于AML治疗的ENL新型小分子抑制剂.
- 为了确定强效和代谢稳定的ENL抑制剂,以便进一步开发.
主要方法:
- 利用一个NanoBRET系统来选ENL抑制剂的细胞透性和功效.
- 评估了抑制剂对MLL融合白血病细胞系的抗增殖作用.
- 在AML异种移植小鼠模型中评估体内疗效和生存益处.
主要成果:
- 抑制剂13表现出代谢稳定性和强大的抗增殖活性.
- 抑制剂13显著改善了AML异种移植小鼠的存活率.
- 优化的抑制剂SR-C-107显示出强大的细胞和体内活性对抗AML.
结论:
- SR-C-107 (R) 是急性髓性白血病治疗的一个有前途的候选药物.
- 这项研究验证了ENL作为AML的治疗点.
- 这些发现支持开发下一代ENL抑制剂用于AML治疗.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


